[HTML][HTML] Auranofin: Past to Present, and repurposing

M Yamashita - International Immunopharmacology, 2021 - Elsevier
Auranofin (AF), a gold compound, has been used to treat rheumatoid arthritis (RA) for more
than 40 years; however, its mechanism of action remains unknown. We revealed that AF …

The lung microbiome in COPD and lung cancer: Exploring the potential of metal-based drugs

M O'Shaughnessy, O Sheils, AM Baird - International Journal of …, 2023 - mdpi.com
Chronic obstructive pulmonary disease (COPD) and lung cancer 17 are two of the most
prevalent and debilitating respiratory diseases worldwide, both associated with high …

Thioredoxin reductase is a valid target for antimicrobial therapeutic development against gram-positive bacteria

LO Felix, E Mylonakis, BB Fuchs - Frontiers in Microbiology, 2021 - frontiersin.org
There is a drought of new antibacterial compounds that exploit novel targets. Thioredoxin
reductase (TrxR) from the Gram-positive bacterial antioxidant thioredoxin system has …

In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci

NS Abutaleb, AEM Elhassanny, DP Flaherty… - PeerJ, 2021 - peerj.com
Vancomycin-resistant enterococci (VRE) are a serious public health threat and a leading
cause of healthcare-associated infections. Bacterial resistance to antibiotics recommended …

In Vivo Antibacterial Activity of Acetazolamide

NS Abutaleb, A Elkashif, DP Flaherty… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
Vancomycin-resistant enterococci (VRE) represent a major public health threat that requires
the development of new therapeutics. In the present study, acetazolamide (AZM) was …

In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection

NS Abutaleb, AEM Elhassanny, MN Seleem - Microbial pathogenesis, 2022 - Elsevier
Gonococcal infections represent an urgent public health threat worldwide due to the
increasing incidence of infections that has been accompanied by an increase in bacterial …

Inhibition of selenoprotein synthesis is not the mechanism by which auranofin inhibits growth of Clostridioides difficile

MA Johnstone, MA Holman, WT Self - Scientific Reports, 2023 - nature.com
Clostridioides difficile infections (CDIs) are responsible for a significant number of antibiotic-
associated diarrheal cases. The standard-of-care antibiotics for C. difficile are limited to …

Targeting Clostridioides difficile: New uses for old drugs

J Chen, Y Li, S Wang, H Zhang, Y Du, Q Wu… - Drug Discovery …, 2022 - Elsevier
Clostridioides difficile bacteria can cause life-threatening diarrhea and colitis owing to
limited treatment options and unacceptably high recurrence rates among infected patients …

Exploring novel aryl/heteroaryl-isosteres of phenylthiazole against multidrug-resistant bacteria

M Omara, M Hagras, MM Elsebaie, NS Abutaleb… - RSC …, 2023 - pubs.rsc.org
Antimicrobial resistance has become a concern as a worldwide threat. A novel scaffold of
phenylthiazoles was recently evaluated against multidrug-resistant Staphylococci to control …

New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation

T Bratkovič, A Zahirović, M Bizjak, M Rupnik… - Gut …, 2024 - Taylor & Francis
Clostridioides difficile causes a range of debilitating intestinal symptoms that may be fatal. It
is particularly problematic as a hospital-acquired infection, causing significant costs to the …